These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23171166)

  • 1. Protocol for a randomised controlled trial to estimate the effects and costs of a patient centred educational intervention in glaucoma management.
    Cate H; Bhattacharya D; Clark A; Fordham R; Notley C; Broadway DC
    BMC Ophthalmol; 2012 Nov; 12():57. PubMed ID: 23171166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving adherence to glaucoma medication: a randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study).
    Cate H; Bhattacharya D; Clark A; Fordham R; Holland R; Broadway DC
    BMC Ophthalmol; 2014 Mar; 14():32. PubMed ID: 24655814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence improvement in Dutch glaucoma patients: a randomized controlled trial.
    Beckers HJ; Webers CA; Busch MJ; Brink HM; Colen TP; Schouten JS;
    Acta Ophthalmol; 2013 Nov; 91(7):610-8. PubMed ID: 23025424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term medical management of primary open-angle glaucoma and ocular hypertension in the UK: optimizing cost-effectiveness and clinic resources by minimizing therapy switches.
    Orme M; Collins S; Loftus J
    J Glaucoma; 2012 Sep; 21(7):433-49. PubMed ID: 21677590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions improve poor adherence with once daily glaucoma medications in electronically monitored patients.
    Okeke CO; Quigley HA; Jampel HD; Ying GS; Plyler RJ; Jiang Y; Friedman DS
    Ophthalmology; 2009 Dec; 116(12):2286-93. PubMed ID: 19815286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: analysis based on the UK general practitioner research database.
    De Natale R; Lafuma A; Berdeaux G
    Clin Drug Investig; 2009; 29(2):111-20. PubMed ID: 19133706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' and physicians' perceptions of the travoprost dosing aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension.
    Flowers B; Wand M; Piltz-Seymour J; Berke SJ; Day D; Teague J; Smoot TM; Landry TA; Bergamini MV; Mallick S;
    Clin Ther; 2006 Nov; 28(11):1803-11. PubMed ID: 17213000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of adherence behaviour for patients with glaucoma.
    Cate H; Bhattacharya D; Clark A; Holland R; Broadway DC
    Eye (Lond); 2013 Apr; 27(4):545-53. PubMed ID: 23328800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for improving adherence to ocular hypotensive therapy.
    Waterman H; Evans JR; Gray TA; Henson D; Harper R
    Cochrane Database Syst Rev; 2013 Apr; (4):CD006132. PubMed ID: 23633333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma.
    Stein JD; Kim DD; Peck WW; Giannetti SM; Hutton DW
    Arch Ophthalmol; 2012 Apr; 130(4):497-505. PubMed ID: 22332202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
    Noecker RJ; Walt JG
    Am J Ophthalmol; 2006 Jan; 141(1 Suppl):S15-21. PubMed ID: 16389056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do adherence rates and glaucomatous visual field progression correlate?
    Rossi GC; Pasinetti GM; Scudeller L; Radaelli R; Bianchi PE
    Eur J Ophthalmol; 2011; 21(4):410-4. PubMed ID: 21140373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring adherence rates in glaucoma patients using the Travatan Dosing Aid. A 6-month study comparing patients on travoprost 0.004% and patients on travoprost 0.004%/timolol 0.5% fixed combination.
    Rossi GC; Pasinetti GM; Scudeller L; Tinelli C; Milano G; Bianchi PE
    Expert Opin Pharmacother; 2010 Mar; 11(4):499-504. PubMed ID: 20163264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of measures used to describe adherence to glaucoma medication in a randomised controlled trial.
    Cate H; Bhattacharya D; Clark A; Holland R; Broadway DC
    Clin Trials; 2015 Dec; 12(6):608-17. PubMed ID: 26183437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: analysis conducted on the United Kingdom General Practitioner Research Database.
    Lafuma A; Berdeaux G
    Curr Med Res Opin; 2007 Dec; 23(12):3009-16. PubMed ID: 17958945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost-effectiveness analysis of fixed-combination therapies in patients with open-angle glaucoma: a European perspective.
    Hommer A; Wickstrøm J; Friis MM; Steeds C; Thygesen J; Ferreras A; Gouws P; Buchholz P
    Curr Med Res Opin; 2008 Apr; 24(4):1057-63. PubMed ID: 18315942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure.
    Dubiner HB; Sircy MD; Landry T; Bergamini MV; Silver LH; Darell Turner F; Robertson S; Andrew RM; Weiner A; Przydryga J
    Clin Ther; 2004 Jan; 26(1):84-91. PubMed ID: 14996520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients.
    Chiselită D;
    Oftalmologia; 2007; 51(2):81-6. PubMed ID: 17937041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
    van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG
    Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): study protocol for a randomised controlled trial.
    Lamoureux EL; Mcintosh R; Constantinou M; Fenwick EK; Xie J; Casson R; Finkelstein E; Goldberg I; Healey P; Thomas R; Ang GS; Pesudovs K; Crowston J
    Trials; 2015 Sep; 16():406. PubMed ID: 26362541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.